{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-015041","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2024-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.936276+00:00","generated_at":"2026-06-03T21:51:29.316639+00:00","sec_items":["5.07","7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ZyVersa shareholders approve reverse stock split; board sets 1-for-10 ratio","bullets":["Shareholders approved reverse stock split at special meeting on April 17, 2024, with 2,058,182 votes for and 899,831 against.","Board of directors subsequently authorized a 1-for-10 reverse stock split ratio.","Reverse stock split effective at 4:01 p.m. ET on April 25, 2024; post-split trading begins April 26, 2024.","New CUSIP number for common stock after reverse split: 98987D 300."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-015041","json":"https://secwatch.observer/filing/0001493152-24-015041.json","markdown":"https://secwatch.observer/filing/0001493152-24-015041.md","text":"https://secwatch.observer/filing/0001493152-24-015041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000149315224015041/0001493152-24-015041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000149315224015041/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T21:51:29.316639+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}